These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19147676)

  • 21. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.
    Hayek T; Azrolan N; Verdery RB; Walsh A; Chajek-Shaul T; Agellon LB; Tall AR; Breslow JL
    J Clin Invest; 1993 Sep; 92(3):1143-52. PubMed ID: 8376576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
    Zhou H; Li Z; Silver DL; Jiang XC
    Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
    Hansen MK; McVey MJ; White RF; Legos JJ; Brusq JM; Grillot DA; Issandou M; Barone FC
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):196-202. PubMed ID: 20332533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis.
    Sammett D; Tall AR
    J Biol Chem; 1985 Jun; 260(11):6687-97. PubMed ID: 3838987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency.
    Inazu A; Nakajima K; Nakano T; Niimi M; Kawashiri MA; Nohara A; Kobayashi J; Mabuchi H
    Atherosclerosis; 2008 Feb; 196(2):953-7. PubMed ID: 17399717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism.
    Whitlock ME; Swenson TL; Ramakrishnan R; Leonard MT; Marcel YL; Milne RW; Tall AR
    J Clin Invest; 1989 Jul; 84(1):129-37. PubMed ID: 2738149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice.
    Pouwer MG; Pieterman EJ; Chang SC; Olsen GW; Caspers MPM; Verschuren L; Jukema JW; Princen HMG
    Toxicol Sci; 2019 Apr; 168(2):519-534. PubMed ID: 30657992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.
    Yamashita S; Ruscica M; Macchi C; Corsini A; Matsuzawa Y; Sirtori CR
    Atherosclerosis; 2018 Nov; 278():286-298. PubMed ID: 30347344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.
    Bijland S; Rensen PC; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; Havekes LM; Willems van Dijk K; Chang SC; Ehresman DJ; Butenhoff JL; Princen HM
    Toxicol Sci; 2011 Sep; 123(1):290-303. PubMed ID: 21705711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein.
    Kinoshita M; Arai H; Fukasawa M; Watanabe T; Tsukamoto K; Hashimoto Y; Inoue K; Kurokawa K; Teramoto T
    J Lipid Res; 1993 Feb; 34(2):261-8. PubMed ID: 8429260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.
    Masucci-Magoulas L; Moulin P; Jiang XC; Richardson H; Walsh A; Breslow JL; Tall A
    J Clin Invest; 1995 Apr; 95(4):1587-94. PubMed ID: 7706465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase.
    Newnham HH; Barter PJ
    Biochim Biophys Acta; 1992 May; 1125(3):297-304. PubMed ID: 1596518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.
    Bijland S; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; van Klinken JB; Havekes LM; van Dijk KW; Princen HM; Rensen PC
    J Biol Chem; 2010 Aug; 285(33):25168-75. PubMed ID: 20501652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.
    Morton RE; Izem L
    J Lipid Res; 2015 Mar; 56(3):612-619. PubMed ID: 25616437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.
    Poliakova T; Wellington CL
    Mol Neurodegener; 2023 Nov; 18(1):86. PubMed ID: 37974180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice.
    Geerling JJ; Boon MR; van der Zon GC; van den Berg SA; van den Hoek AM; Lombès M; Princen HM; Havekes LM; Rensen PC; Guigas B
    Diabetes; 2014 Mar; 63(3):880-91. PubMed ID: 24270984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.